Nita J. Maihle

University of Mississippi Medical Center — United States

Medicine · Health Sciences

47h-index6.9kcitations154works7.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(58), Monoclonal and Polyclonal Antibodies Research(41), Cell Adhesion Molecules Research(13), Lung Cancer Treatments and Mutations(12), Glycosylation and Glycoproteins Research(12)

Publications154 total

Influence of antibody–drug conjugate cleavability, drug-to-antibody ratio, and free payload concentration on systemic toxicities: A systematic review and meta-analysis
Cancer and Metastasis Reviews·2024· 15 citedOpen Access
Associations of smoking and bacterial vaginosis with cervical precancer in strides: studying risk and improving disparities in cervical cancer
The American Journal of the Medical Sciences·2024
The impact of breathing patterns on CSF flow and global brain BOLD signal while awake: A study using real‐time phase‐contrast MRI and fast rsfMRI
Alzheimer s & Dementia·2023· 1 citedOpen Access
Belief in Research, Religious Coping, and Willingness to Participate in Clinical Trials Among African American Patients With Hematologic Malignancies: A Pilot Study
Journal of Clinical Pathways·2023
A Pilot Randomized Controlled Trial Evaluating Essential Oils for Chemotherapy-Induced Peripheral Neuropathy
Pain Management Nursing·2023· 7 cited
Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cells
Biochemistry and Biophysics Reports·2022· 6 citedOpen Access
Identification of novel lipid biomarkers in xmrk- and Myc-induced models of hepatocellular carcinoma in zebrafish
Cancer & Metabolism·2022· 3 citedOpen Access
Cross‐talk between <scp>EGFR</scp> and <scp>BMP</scp> signals regulates chondrocyte maturation during endochondral ossification
Developmental Dynamics·2021· 10 cited
Systemic toxicities of trastuzumab‐emtansine predict tumor response in <scp>HER2</scp>+ metastatic breast cancer
International Journal of Cancer·2021· 7 citedOpen Access
The Ovarian Cancer Academy 2015-2020: A Team-Based Science Approach
2019
Introduction: the 12th Biennial Rivkin Center Ovarian Cancer Research Symposium
International Journal of Gynecological Cancer·2019· 3 citedOpen Access
Development and characterization of a chimeric siRNA-aptamer with inhibitory activity in HER2/3+ cells
Gynecologic Oncology·2019
Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis
Clinical Breast Cancer·2019· 9 cited
The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis
Journal of Biological Chemistry·2019· 45 citedOpen Access
Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth
Molecular Pharmaceutics·2018· 45 citedOpen Access
Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer
Molecular Therapy — Nucleic Acids·2017· 93 citedOpen Access
Enhancing diversity in the hematology biomedical research workforce: A mentoring program to improve the odds of career success for early stage investigators
American Journal of Hematology·2017· 12 citedOpen Access
Anti-HER-2 therapy following severe trastuzumab-induced cardiac toxicity
Genes & Diseases·2017· 6 citedOpen Access
Abstract 4240: Determination of normative patterns of gene expression levels and breast cancer risk biomarkers in human breast milk
Cancer Research·2017
Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis
Oncotarget·2017· 26 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Andre T. Baron(9), Margot P. Cleary(8), Jason A. Wilken(7), Joseph P. Grande(7), Jacqueline M. Lafky(5), Subhash C. Juneja(5), Cecelia H. Boardman(4), Karl C. Podratz(4), Frederick C. Phillips(3), Jill L. Reiter(3), Elsa M. Cora(3), Junqi Qian(2), Robert B. Jenkins(2), Michelle K. Jacobson(2), Susan C. Getzin(2), Lingeng Lu(2), Trace Christensen(2), Xin Hu(2), Inder Sehgal(2), Mark R. Pittelkow(2)